- Home
- NLSP vs RCAT Comparison
NLSP vs RCAT Comparison
Compare NLSP & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- RCAT
- Stock Information
- Founded
- NLSP 2015
- RCAT 2002
- Country
- NLSP Switzerland
- RCAT United States
- Employees
- NLSP N/A
- RCAT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- RCAT Wholesale Distributors
- Sector
- NLSP Health Care
- RCAT Industrials
- Exchange
- NLSP Nasdaq
- RCAT Nasdaq
- Market Cap
- NLSP 12.4M
- RCAT 1.5B
- IPO Year
- NLSP 2021
- RCAT 2017
- Fundamental
- Price
- NLSP $1.65
- RCAT $11.72
- Analyst Decision
- NLSP
- RCAT Strong Buy
- Analyst Count
- NLSP 0
- RCAT 2
- Target Price
- NLSP N/A
- RCAT $15.00
- AVG Volume (30 Days)
- NLSP 899.5K
- RCAT 16.9M
- Earning Date
- NLSP 10-06-2025
- RCAT 11-14-2025
- Dividend Yield
- NLSP N/A
- RCAT N/A
- EPS Growth
- NLSP N/A
- RCAT N/A
- EPS
- NLSP N/A
- RCAT N/A
- Revenue
- NLSP N/A
- RCAT N/A
- Revenue This Year
- NLSP N/A
- RCAT $972.37
- Revenue Next Year
- NLSP N/A
- RCAT $91.52
- P/E Ratio
- NLSP N/A
- RCAT N/A
- Revenue Growth
- NLSP N/A
- RCAT N/A
- 52 Week Low
- NLSP $1.30
- RCAT $2.66
- 52 Week High
- NLSP $5.64
- RCAT $16.70
- Technical
- Relative Strength Index (RSI)
- NLSP 37.17
- RCAT 47.53
- Support Level
- NLSP $1.45
- RCAT $13.01
- Resistance Level
- NLSP $1.89
- RCAT $16.20
- Average True Range (ATR)
- NLSP 0.17
- RCAT 1.67
- MACD
- NLSP -0.03
- RCAT -0.13
- Stochastic Oscillator
- NLSP 26.67
- RCAT 25.64
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.